Cargando…
Pharmacokinetics comparison of solifenacin tartrate and solifenacin succinate: a randomized, open-label, single-dose, 2-way crossover study in healthy male volunteers
Solifenacin is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms. Solifenacin tartrate is a newly developed salt formulation of solifenacin. This study compared the pharmacokinetic and safety properties after single-dose administration of solifenacin tartrate (t...
Autores principales: | Kim, Yu-mi, Jeon, Ji-Young, Moon, Seol Ju, Jung, Jina, Son, Hankil, Kim, Min-Gul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Clinical Pharmacology and Therapeutics
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989256/ https://www.ncbi.nlm.nih.gov/pubmed/32055552 http://dx.doi.org/10.12793/tcp.2018.26.2.73 |
Ejemplares similares
-
Spectrophotometric estimation of solifenacin succinate in tablet formulations
por: Singh, Lokesh, et al.
Publicado: (2011) -
Transcutaneous electrical nerve stimulation and solifenacin succinate versus solifenacin succinate alone for treatment of overactive bladder syndrome: A double-blind randomized controlled study
por: Zhang, Yumeng, et al.
Publicado: (2021) -
A Comparative Study on the Efficacy of Solifenacin Succinate in Patients with Urinary Frequency with or without Urgency
por: Han, Ji-Yeon, et al.
Publicado: (2014) -
Novel Bioequivalent Tablet of Solifenacin Succinate Prepared Using Direct Compression Technique for Improved Chemical Stability
por: Kim, Do Hwan, et al.
Publicado: (2023) -
Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)